The role of fibroblast growth factor-2 in the vascular effects ofinterleukin-1β in porcine coronary arteries in vivo

Cardiovascular Research

Volumn 32, Issue 3, 1996, Pages 570-579

  Ito, Akira ^a   Shimokawa, Hiroaki ^a   Fukumoto, Yoshihiro ^a   Kadokami, Toshiaki ^a   Nakaike, Ryuichi ^a   Takayanagi, Tsuneo ^a   Egashira, Kensuke ^a   Sueishi, Katsuo ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Coronary artery; Fibroblast growth factor; Interleukins; Pig

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR ANTIBODY; HISTAMINE; INTERLEUKIN 1BETA ANTIBODY; RECOMBINANT INTERLEUKIN 1BETA; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE; VASOSPASM;

ANIMALS; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; FIBROBLAST GROWTH FACTOR 2; HISTAMINE; INTERLEUKIN-1; MALE; SEROTONIN; SWINE; TUNICA INTIMA; VASOCONSTRICTION;

EID: 0030245555     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00120-4     Document Type: Article

References (33)

1. [1] Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
2. [2] Munro JM, Cotran RS. Biology of disease. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 1988;58:249-261.
3. [3] Hannson GK, Jonasson L, Seifen PS, Stemme S. Immune mechanisms in atherosclerosis. Arteriosclerosis 1989;9:567-578.
4. [4] Shimokawa H, Tomoike H, Nabeyama S, et al. Coronary artery spasm induced in atherosclerotic miniature swine. Science 1983;221:560-562.
5. [5] Shimokawa H, Tomoike H, Nabeyama S, et al. Coronary artery spasm induced in miniature swine: angiographic evidence and relation to coronary atherosclerosis. Am Heart J 1985;110:300-310.
6. [6] Egashira K, Tomoike H, Yamamoto Y, Yamada A, Hayashi Y, Nakamura M. Histamine-induced coronary spasm in regions of intimal thickening in miniature pigs: roles of serum cholesterol and spontaneous or induced intimal thickening. Circulation 1986;74:826-837.
7. [7] Ross R, Glomset J. Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 1974;71:1207-1210.
8. [8] Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC, Gospodarowicz D. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 1987;325:257-259.
9. [9] Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991;251:936-939.
10. [10] Banskota NK, Taub R, Zellner K, Olsen P, King GL. Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes 1989;38:123-129.
11. [11] Dinarello CA. Biology of interleukin-1. FASEB J 1988;2:108-115.
12. [12] Moyer CF, Sajuthi D, Tulli H, Williams JK. Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am J Pathol 1991;138:951-960.
13. [13] Shimokawa H, Ito A, Fukumoto Y, et al. Chronic treatment with interleukin-1β induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J Clin Invest 1996;97:769-776.
14. [14] Brogi E, Winkles J, Libby P. Regional expression of acidic and basic fibroblast growth factor in human atheroma and non-atherosclerotic arteries. Circulation 1992;86:I-85.
15. [15] Hughes SE, Crossman D, Hall PA. Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res 1993;27:1214-1219.
16. [16] Kita M, Ohmoto Y, Hirai Y, Yamaguchi N, Imanishi J. Induction of cytokines in human peripheral blood mononuclear cells by mycoplasmas. Microbiol Immunol 1992;36:507-516.
17. [17] Ito A, Shimokawa H, Nakaike R, et al. Role of protein kinase C-mediated pathway in the pathogenesis of coronary artery spasm in a swine model. Circulation 1994;90:2425-2431.
18. [18] Watanabe H, Hori A, Seno M, et al. A sensitive enzyme immunoassay for human basic fibroblast growth factor. Biochem Biophys Res Commun 1991;175:229-235.
19. [19] Libby P, Warner SJ.C, Friedman G. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 1988;81:487-498.
20. [20] Ikeda, U; Ikeda, M. Oohara T, Kano S, Yaginuma T. Mitogenic action of interleukin-1α on vascular smooth muscle cells mediated by PDGF. Atherosclerosis 1990;84:183-188.
21. [21] Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 1989;243:393-396.
22. [22] Ito A, Shimokawa H, Kadokami T, et al. Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1β in pigs in vivo. J Clin Invest 1995;96:1288-1294.
23. [23] Ek B. Westemark B, Wasteson A, Heldin CH. Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor. Nature (Lond) 1982;295:419-420.
24. [24] Hanks SK, Quinn AM, Hunter T. The protein kinase family: Conserved features and deduced physiology of the catalytic domains. Science 1988;241:42-52.
25. [25] Ullrich A, Bell JR, Chen EY, et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature (Lond) 1985;313:756-761.
26. [26] Winkles JA, Friesel R, Burgess WH, et al. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proc Natl Acad Sci USA 1987;84:7124-7128.
27. [27] Lindner V, Lappi DA, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991;68:106-113.
28. [28] Cuevas, P, Gonzalez AM, Carceller F, Baird A. Vascular response to basic fibroblast growth factor when infused onto the normal adventitia or into the injured media of the rat carotid artery. Circ Res 1991;69:360-369.
29. [29] Nabel, EG, Yang Z, Plautz G, et al. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature (Lond) 1993;362:844-846.
30. [30] Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Giménez-Gallego G. Hypotensive activity of fibroblast growth factor. Science 1991;254:1208-1210.
31. [31] Nakaike R, Shimokawa H, Yasutake H, et al. Vanadate causes the synthesis of endothelium-derived nitric oxide via pertussis toxin-sensitive G-protein in pigs. Am J Physiol 1996;in press.
32. [32] Shimokawa H, Takeshita A, Endothelium-dependent regulation of the cardiovascular system. Intern Med 1995;34:939-946.
33. [33] Kadokami T, Shimokawa H, Fukumoto Y, et al. Coronary artery spasm does not depend on the intracellular calcium store but is substancially mediated by the protein kinase C-mediated pathway in a swine model with interleukin-1β in vivo. Circulation 1996;94: 190-196.